Pomalidomide Capsule
Product Images NDC 60505-4497

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Pomalidomide (NDC 60505-4497). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Btl-lbl-1mg-21s (Btl Lbl 1mg 21s)

Each capsule contains 1 mg of pomalidomide. Store at 20°- 25°C (68° - 77°F); excursions permitted from 15°-30°C (59° - 86°F). Dispense in a tight container. The usual dosage can be found in the package insert. This medicine is distributed by Apotex Corp.*

FDA Label Image

Btl-lbl-2mg-21s (Btl Lbl 2mg 21s)

This text provides information about a medication called Pomalidomide Capsules. Each capsule contains 2 mg of Pomalidomide and should be stored at a temperature between 20°-25°C (68°-77°F). Excursions are permitted between 15°-30°C (59°-86°F). The medication should be dispensed in a tight container and the usual dosage can be found in the package insert. The product is manufactured for Apotex Corp in Weston, Florida.*

FDA Label Image

Btl-lbl-3mg-21s (Btl Lbl 3mg 21s)

This text refers to a medication called pomalidomide capsules, with each capsule containing 3 mg of the active ingredient. The storage instructions recommend keeping the capsules at a temperature between 20°C-25°C (68°F-77°F), with excursions allowed between 15°C-30°C (59°F-86°F). It should be dispensed in a tight container as per USP guidelines. The label mentions 21 capsules in the package with NDC code 60505-4499.2. The medication is produced for Apotex Corp in Canada and distributed in Weston, Florida. For specific dosage information and other details, it also advises referring to the package insert.*

FDA Label Image

Btl-lbl-4mg-21s (Btl Lbl 4mg 21s)

Each capsule contains 4 mg of pomalidomide and is recommended to be stored at a temperature range of 20°-25°C (68°-77°F) with excursions permitted from 15°-30°C (59°-86°F). The medication should be dispensed in a tight container. For information on the usual dosage, refer to the package insert. The product is presented as 21 Capsules with NDC 60505-4500-2. This medication guide is provided to each patient by Apotex Corp, a pharmaceutical company based in Weston, Florida.*

FDA Label Image

Figure-1 (Figure 1)

This text appears to be a comparison study between two groups, POM+LD-DEX and HD-DEX, evaluating event outcomes. The study shows a significant difference between the two groups based on the logrank p-value of <0.001, with a Hazard Ratio (HR) of 0.45 and 95% Confidence Interval (CI) of 0.35 to 0.59. The Kaplan-Meier (KM) median for POM+LD-DEX is 3.6 and for HD-DEX is 18. The number of events experienced by each group is provided (164/302 for POM+LD-DEX and 103/153 for HD-DEX). The figure shows the proportion of subjects at different time points along with the number of subjects at risk.*

FDA Label Image

Figure-2 (Figure 2)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.